Tag: 2017 source edit
Line 7: Line 7:
| routes =Intravenous  
| routes =Intravenous  
| dosage =Based upon response to train-of-four stimulation:
| dosage =Based upon response to train-of-four stimulation:
* 2+ twitches: 2 mg/kg
* 2+ twitches: 2 mg/kg
* 1-2 posttetanic twitches: 4 mg/kg
* 1-2 posttetanic twitches: 4 mg/kg
<br/>
Reversal immediately after administration of rocuronium 1.2 mg/kg: 16 mg/kg  
Reversal immediately after administration of rocuronium 1.2 mg/kg: 16 mg/kg  
|halflife_elimination=|formula=C<sub>72</sub>H<sub>112</sub>O<sub>48</sub>S<sub>8</sub>|image_file=Sugammadex.svg|protein_binding=|clearance=|time_onset=|halflife_redistribution=|metabolism=|duration=|adverse_effects=Bradycardia, may interfere with hormonal contraceptives|mechanism=Encapsulation of rocuronium or vecuronium|molar_mass=2002.12 g/mol}}
|halflife_elimination=|formula=C<sub>72</sub>H<sub>112</sub>O<sub>48</sub>S<sub>8</sub>|image_file=Sugammadex.svg|protein_binding=|clearance=|time_onset=|halflife_redistribution=|metabolism=|duration=|adverse_effects=Bradycardia, may interfere with hormonal contraceptives|mechanism=Encapsulation of rocuronium or vecuronium|molar_mass=2002.12 g/mol}}

Revision as of 07:40, 21 February 2021

Sugammadex
Trade names

Bridion

Sugammadex.svg
Clinical data
Uses

Reversal of neuromuscular blockade from rocuronium and vecuronium

Contraindications

Renal impairment

Routes of administration

Intravenous

Dosage

Based upon response to train-of-four stimulation:

  • 2+ twitches: 2 mg/kg
  • 1-2 posttetanic twitches: 4 mg/kg

Reversal immediately after administration of rocuronium 1.2 mg/kg: 16 mg/kg

Pharmacodynamics
Mechanism of action

Encapsulation of rocuronium or vecuronium

Adverse effects

Bradycardia, may interfere with hormonal contraceptives

Pharmacokinetics
Physical and chemical data
Formula

C72H112O48S8

Molar mass

2002.12 g/mol

Article quality
Editor rating
In development
User likes
0

Sugammadex is used to reverse neuromuscular blockade from rocuronium and vecuronium.

Uses

If a patient requires reparaylsis after administration of sugammadex (up to 4 mg/kg), rocuronium or vecuronium can be re-administered after a minimum waiting time.[1]

Drug and dose to be administered Minimum waiting time
Rocuronium 1.2 mg/kg 5 minutes
Rocuronium 0.6 mg/kg or

vecuronium 0.1 mg/kg

4 hours

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References

  1. "BRIDION® (sugammadex) Injection Drug Label (FDA)" (PDF).